Yung H. Chyung
Nessuna posizione attualmente
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Yung H.
Chyung is currently the Chief Medical Officer at Tourmaline Bio, Inc. Prior to this, he was the Chief Medical Officer at Scholar Rock, Inc. and Scholar Rock Holding Corp.
from 2016 to 2022.
He was also the Vice President-Medical Research at Dyax Corp.
from 2011 to 2016.
Dr. Chyung received his doctorate degree from Harvard Medical School in 2003 and his undergraduate degree from Harvard College in 1997.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
0.22% | 23/10/2023 | 56 836 ( 0.22% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Yung H. Chyung
Società | Posizione | Inizio |
---|
Precedenti posizioni note di Yung H. Chyung
Società | Posizione | Fine |
---|---|---|
SCHOLAR ROCK HOLDING CORPORATION | Chief Tech/Sci/R&D Officer | 30/06/2022 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 30/06/2022 |
DYAX CORP. | Corporate Officer/Principal | 01/02/2016 |
Formazione di Yung H. Chyung
Harvard Medical School | Doctorate Degree |
Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
Aziende private | 2 |
---|---|
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Yung H. Chyung